China's survival vaccine safety is recognized again

For a long time, the safety of the new crown vaccine has attracted much attention. Just recently, the Kotoic vaccine was approved in Hong Kong for vaccination as low as June. Obviously, the safety of domestic new coronal virus activity vaccines has been highly recognized.

On August 2nd, the director of the Medical and Health Bureau of the Hong Kong Special Administrative Region approved the minimum vaccination age of Corchlon in China Kexing New Crown Vaccine, from 3 years to 6 months, and announced that it began to take over on August 4. Hong Kong became the world's first region to use new crown virus to be used as low as Children as low as June.

With the efforts from all walks of life in Hong Kong, a total of 2,200 in the first week of June to 3 -year -old infants and young children vaccinated the new crown vaccine. On August 11, Liu Yulong, an expert in Hong Kong Government, said that some studies have pointed out that children's risk of new crown virus infection of new crown virus is 2 to 3 times higher than that of influenza. Children in East Asia are more likely to have acute necrotic encephalitis than Europe and the United States. The new crown vaccine produced by Kexing uses a classic activation technology, which is very safe and can be vaccinated with other vaccines. Therefore, parents call on parents to take their children as soon as possible.

On the same day, Yang He Beiyin, director of the Civil Service Bureau of the Hong Kong Special Administrative Region Government, also publicly spoke publicly, hoping to increase the new crown vaccination channels, especially for children and the elderly to launch targeted convenience measures for children and the elderly.

Yang Hebein revealed that from the 15th, the mother and infant health hospital under the Department of Health will be vaccinated for the Children's Children who receive conventional services without appointments. For example, when you go to other vaccines or test, hearing, vision and other tests, as long as the parents agree, they will take the new crown vaccine for young children. The vaccination station that was originally provided by the Fubitai vaccine will also provide appointments for children to take vaccines from the Coroxing vaccine from the 12th.

So far, the Koxing New Crown Vaccine has approved inocus for children and adolescents in 14 countries and regions including Indonesia, Thailand, Brazil, Brazil, Chile, and Colombia. Essence

- END -